These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 16741025)
21. Effect of systemic insulin and angiotensin II receptor subtype-1 antagonist on endothelin-1 receptor subtype(s) regulation and binding in diabetic rat heart. Karam CN; Nuwayri-Salti N; Usta JA; Zwainy DS; Abrahamian RE; Al Jaroudi WA; Baasisri MJ; Abdallah SM; Bitar KM; Bikhazi AB Endothelium; 2005; 12(5-6):225-31. PubMed ID: 16410221 [TBL] [Abstract][Full Text] [Related]
22. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1. Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023 [TBL] [Abstract][Full Text] [Related]
23. Cyclohexenonic long-chain fatty alcohol has therapeutic effects on diabetes-induced angiopathy in the rat aorta. Shinbori C; Saito M; Kinoshita Y; Satoh I; Kono T; Hanada T; Nanba E; Adachi K; Suzuki H; Yamada M; Satoh K Eur J Pharmacol; 2007 Jul; 567(1-2):139-44. PubMed ID: 17499713 [TBL] [Abstract][Full Text] [Related]
24. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Ling Y; Zhang J; Luo B; Song D; Liu L; Tang L; Stockard CR; Grizzle WE; Ku DD; Fallon MB Hepatology; 2004 Jun; 39(6):1593-602. PubMed ID: 15185300 [TBL] [Abstract][Full Text] [Related]
27. [Aortic endothelium-dependent vasodilation function and PI3K-, PKB-, eNOS mRNA expressions in insulin-resistant and type 2 diabetic rats]. Wu J; Lei MX; Liu L; Xie XY Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Mar; 35(3):265-70. PubMed ID: 17582297 [TBL] [Abstract][Full Text] [Related]
28. [Effect of beta3-adrenoceptor antagonist on the cardiac function and expression of endothelial nitric oxide synthase in a rat model of heart failure]. Gan RT; Li WM; Wang X; Wu S; Kong YH Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):675-8. PubMed ID: 17996136 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetes. Cheng X; Cheng XS; Kuo KH; Pang CC Cardiovasc Res; 2004 Nov; 64(2):298-307. PubMed ID: 15485689 [TBL] [Abstract][Full Text] [Related]
30. Antioxidative treatment reverses imbalances of nitric oxide synthase isoform expression and attenuates tissue-cGMP activation in diabetic rats. Bojunga J; Dresar-Mayert B; Usadel KH; Kusterer K; Zeuzem S Biochem Biophys Res Commun; 2004 Apr; 316(3):771-80. PubMed ID: 15033467 [TBL] [Abstract][Full Text] [Related]
31. Role of endothelin receptors and relationship with nitric oxide synthase in impaired erectile response in diabetic rats. Alkan E; Ugan RA; Basar MM; Halici Z; Karakus E; Balbay MD; Un H Andrologia; 2017 Mar; 49(2):. PubMed ID: 27145076 [TBL] [Abstract][Full Text] [Related]
32. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin. Wang C; Li J; Lv X; Zhang M; Song Y; Chen L; Liu Y Eur J Pharmacol; 2009 Oct; 620(1-3):131-7. PubMed ID: 19686728 [TBL] [Abstract][Full Text] [Related]
33. Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Wölkart G; Stessel H; Saad Z; Kirchengast M; Brunner F Br J Pharmacol; 2006 Jul; 148(5):671-81. PubMed ID: 16702986 [TBL] [Abstract][Full Text] [Related]
34. Tubular and glomerular L-arginine transport (uptake and transporters) and the nitric oxide synthases in ischemic acute renal failure (iARF) in streptozotocin-induced diabetic rats (STZ-DM). Levin-Iaina N; Schwartz I; Chernichovsky T; Davidovitch A; Iaina A; Schwartz D Ren Fail; 2007; 29(8):1031-8. PubMed ID: 18067052 [TBL] [Abstract][Full Text] [Related]
35. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats. Soliman H; Craig GP; Nagareddy P; Yuen VG; Lin G; Kumar U; McNeill JH; Macleod KM Cardiovasc Res; 2008 Jul; 79(2):322-30. PubMed ID: 18411229 [TBL] [Abstract][Full Text] [Related]
36. Effects of hydrogen sulfide on inducible nitric oxide synthase activity and expression of cardiomyocytes in diabetic rats. Yang R; Jia Q; Liu XF; Wang YY; Ma SF Mol Med Rep; 2017 Oct; 16(4):5277-5284. PubMed ID: 28849194 [TBL] [Abstract][Full Text] [Related]
37. The effect of flutamide on systemic and renal hemodynamics in Zucker diabetic rats: paradoxic renal vasodilator response to endothelin-1 and TXA2 receptor activation in female sex. Ajayi AA; Fidelis P J Cardiovasc Pharmacol; 2006 Nov; 48(5):191-8. PubMed ID: 17110800 [TBL] [Abstract][Full Text] [Related]
38. [Expressions of NOS isoforms in the cavernous tissues of diabetic rat models]. Yao LS; Wang YT; Chen Y; Dai YT Zhonghua Nan Ke Xue; 2009 Oct; 15(10):915-9. PubMed ID: 20112741 [TBL] [Abstract][Full Text] [Related]
39. Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats. Malyshev E; Tazi KA; Moreau R; Lebrec D J Gastroenterol Hepatol; 2007 Dec; 22(12):2195-201. PubMed ID: 18031380 [TBL] [Abstract][Full Text] [Related]
40. Hypercholesterolaemia induces early renal lesions characterized by upregulation of MMP-9 and iNOS and ET(A)R: alleviated by a dual endothelin receptor antagonist CPU0213 and simvastatin. Luo L; Zheng YF; Dai Y; Dai DZ J Pharm Pharmacol; 2009 Jun; 61(6):775-80. PubMed ID: 19505368 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]